Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

• Main Authors: M. Liontos (Author), A. Andrikopoulou (Author), K. Koutsoukos (Author), C. Markellos (Author), E. Skafida (Author), O. Fiste (Author), M. Kaparelou (Author), N. Thomakos (Author), D. Haidopoulos (Author), A. Rodolakis (Author), M. A. Dimopoulos (Author), F. Zagouri (Author)
• Format: Book
• Published: BMC, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Ne...